HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LEADS BIOLABS-B

72.300

+0.3500.49%

Volume:1.44M

Turnover:103.17M

Market Cap:14.39B

PE:-51.24

High:73.850

Open:73.850

Low:69.750

Close:71.950

52wk High:97.500

52wk Low:44.720

Shares:199.00M

HK Float Shares:198.00M

Volume Ratio:0.97

T/O Rate:0.73%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.411

ROE:-27.61%

ROA:-9.92%

PB:9.75

PE(LYR):-51.24

PS:69.61

Loading ...

Overview Company News Filings

Nanjing Leads Biolabs Completes Enrollment in Phase II Opamtistomig Trial for Advanced Biliary Tract Cancer

LEADS BIOLABS-B (09887) Records a Major Securities Transfer Valued at HK$746 Million, Representing 7.10% of Total Shares, with 13.76 Million Shares Moved from China Securities Depository and Clearing Hong Kong

Hong Kong Stocks Update: LEADS BIOLABS-B (09887) Drops Over 7% Further, Kpc Pharmaceuticals Plans to Sell HKD 132 Million Stake, Founder Voluntarily Extends Lock-Up Period

Movement Alert｜LEADS BIOLABS-B Falls 5.51% in Regular Trading, Lock-Up Expiry Triggers Selling Pressure as Kunming Pharma Exits Position

KPC Pharmaceuticals to Divest Stake in Nanjing Leads Biolabs

MT Newswires Live

Hong Kong Stock Market Midday Review: Hang Seng Index Rises 0.81% as Xiaomi Leads the Blue Chips with a 7% Gain

New Forecasts: Here's What Analysts Think The Future Holds For Nanjing Leads Biolabs Co., Ltd. (HKG:9887)

Simply Wall St.

LEADS BIOLABS-B Shares Surge Over 11%, Marking a 30% Gain in Three Days on ESMO Research News

LEADS BIOLABS-B Shares Surge Over 15% as Key Drug Candidate LBL-024 Enters Priority Review

Leads Biolabs Says Six Studies Accepted for Presentation at ESMO 2026

Leads Biolabs Highlights R&D Momentum with Six Abstracts Accepted by 2026 ESMO, Including Two Top-Tier Oral Presentations

Bulletin Express

LEADS BIOLABS-B Announces Multiple Research Presentations Selected for Prestigious 2026 ESMO Congress

Nanjing Leads Biolabs Says Six Clinical Studies Win Presentation Slots at 2026 ESMO Meeting

LEADS BIOLABS-B Surges Over 27% in Morning Session as Velixicon® Application Granted Priority Review

Nanjing Leads Biolabs Co - Opamtistomig Bla for Advanced Ep-nec Granted Priority Review by China's Nmpa

THOMSON REUTERS

Nanjing Leads Biolabs Co Ltd: Actively Advancing Relevant Pre-launch Commercialization Preparations

THOMSON REUTERS

Priority Review Granted to Pd-l1/4-1bb Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in Ep-nec

THOMSON REUTERS

Nanjing Leads Biolabs' Cancer Drug Included in China Regulator's Priority Review List

MT Newswires Live

LEADS BIOLABS-B's Novel Cancer Therapy LBL-024 Granted Priority Review in China for Advanced Neuroendocrine Carcinoma

Nanjing Leads Biolabs Says China Regulator Puts Lbl-024 Ep-nec Filing in Priority Review

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/09887/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09887","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","market":"HK","secType":"STK","nameCN":"LEADS BIOLABS-B","latestPrice":72.3,"timestamp":1788163728010,"preClose":71.95,"halted":0,"volume":1444087,"delay":0,"changeRate":0.004864489228630914,"floatShares":198000000,"shares":199000000,"eps":-1.4110233338297422,"marketStatus":"Closed","change":0.35,"latestTime":"08-31 16:08:48","open":73.85,"high":73.85,"low":69.75,"amount":103174580,"amplitude":0.056984,"askPrice":72.3,"askSize":36900,"bidPrice":72.25,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.3725408792707492,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788226200000},"marketStatusCode":5,"adr":0,"listingDate":1753372800000,"exchange":"SEHK","adjPreClose":71.95,"openAndCloseTimeList":[[1788139800000,1788148800000],[1788152400000,1788163200000]],"volumeRatio":0.974167,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","floatShares":198000000,"roa":"-9.92%","roe":"-27.61%","lyrEps":-1.411023,"volumeRatio":0.974167,"shares":199000000,"dividePrice":0,"high":73.85,"amplitude":0.056984,"preClose":71.95,"low":69.75,"week52Low":44.72,"pbRate":"9.75","psRate":"69.61","week52High":97.5,"institutionHeld":0,"latestPrice":72.3,"committee":-0.989218,"eps":-1.4110233338297422,"divideRate":0,"volume":1444087,"delay":0,"ttmEps":-1.3725408792707492,"open":73.85,"prevYearClose":51,"prevWeekClose":71.95,"prevMonthClose":53.4,"prevQuarterClose":49.32,"fiveDayClose":69.05,"twentyDayClose":56.95,"sixtyDayClose":56.85},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09887\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"date":"2026-03-27","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774575000000,"name":null,"time":"","dateTimestamp":1774540800000,"actualEps":null},{"date":"2025-08-29","symbol":"09887","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09887\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09887\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1780243200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09887\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09887","date":"2026-08-28","current":-52.676027,"percent":0.130597,"low":-76.458084,"twenty":-45.572671,"median":-39.940552,"eighty":-34.653517,"high":-30.202688,"avg":-42.108117,"sd":9.834997,"marketCap":14310265010},"quantilePoints":[{"date":"2025-07-25","current":-39.760016,"twenty":-39.760016,"median":-39.760016,"eighty":-39.760016,"marketCap":12652000240},{"date":"2025-08-01","current":-42.800562,"twenty":-46.836196,"median":-44.399434,"eighty":-42.800562,"marketCap":13535375000},{"date":"2025-08-08","current":-41.931377,"twenty":-45.734702,"median":-43.894587,"eighty":-42.800562,"marketCap":13293671875},{"date":"2025-08-15","current":-42.360797,"twenty":-44.683717,"median":-42.975881,"eighty":-41.70245,"marketCap":13409689375},{"date":"2025-08-22","current":-41.268557,"twenty":-45.0887,"median":-43.050098,"eighty":-41.70245,"marketCap":13022964375},{"date":"2025-08-29","current":-41.462871,"twenty":-44.683717,"median":-42.745269,"eighty":-41.268557,"marketCap":13146747980},{"date":"2025-09-05","current":-41.718992,"twenty":-44.115151,"median":-41.93996,"eighty":-40.603026,"marketCap":13087080440},{"date":"2025-09-12","current":-41.612383,"twenty":-43.894587,"median":-41.766832,"eighty":-40.253447,"marketCap":13077135850},{"date":"2025-09-19","current":-40.406926,"twenty":-43.894587,"median":-41.814673,"eighty":-40.270938,"marketCap":12689296840},{"date":"2025-09-26","current":-39.940552,"twenty":-43.592616,"median":-41.710721,"eighty":-39.940552,"marketCap":12510294220},{"date":"2025-10-03","current":-46.021818,"twenty":-44.124681,"median":-41.829747,"eighty":-40.190868,"marketCap":14449489270},{"date":"2025-10-10","current":-44.344385,"twenty":-44.480118,"median":-41.935668,"eighty":-40.263942,"marketCap":13902536820},{"date":"2025-10-17","current":-41.267963,"twenty":-44.480118,"median":-42.061577,"eighty":-40.352531,"marketCap":12927967000},{"date":"2025-10-24","current":-37.571928,"twenty":-44.331016,"median":-41.888099,"eighty":-40.263942,"marketCap":11774394560},{"date":"2025-10-31","current":-34.030535,"twenty":-44.258383,"median":-41.766832,"eighty":-39.846145,"marketCap":10680489660},{"date":"2025-11-07","current":-37.063837,"twenty":-44.143742,"median":-41.612383,"eighty":-39.421071,"marketCap":11625225710},{"date":"2025-11-14","current":-37.306884,"twenty":-44.026925,"median":-41.504614,"eighty":-38.171485,"marketCap":11734616200},{"date":"2025-11-21","current":-32.263354,"twenty":-43.773799,"median":-41.293984,"eighty":-37.626872,"marketCap":10143481800},{"date":"2025-11-28","current":-33.407237,"twenty":-43.416049,"median":-41.25873,"eighty":-37.278832,"marketCap":10541265400},{"date":"2025-12-05","current":-32.531883,"twenty":-43.110759,"median":-40.854935,"eighty":-36.232015,"marketCap":10282706060},{"date":"2025-12-12","current":-33.445348,"twenty":-43.033782,"median":-40.504976,"eighty":-34.804627,"marketCap":10590988350},{"date":"2025-12-19","current":-31.455565,"twenty":-42.962519,"median":-40.253447,"eighty":-33.697999,"marketCap":9984368360},{"date":"2025-12-24","current":-31.920084,"twenty":-42.892338,"median":-39.907071,"eighty":-33.445348,"marketCap":10163370980},{"date":"2026-01-02","current":-31.421623,"twenty":-42.818917,"median":-39.811672,"eighty":-33.24713,"marketCap":10044035900},{"date":"2026-01-09","current":-34.757237,"twenty":-42.712093,"median":-39.628079,"eighty":-33.303022,"marketCap":11137940800},{"date":"2026-01-16","current":-34.953981,"twenty":-42.570843,"median":-39.220132,"eighty":-33.387129,"marketCap":11237386700},{"date":"2026-01-23","current":-34.708884,"twenty":-42.534258,"median":-38.04671,"eighty":-33.234922,"marketCap":11147885390},{"date":"2026-01-30","current":-41.208386,"twenty":-42.402729,"median":-37.93488,"eighty":-33.285275,"marketCap":13295916830},{"date":"2026-02-06","current":-38.552413,"twenty":-42.362692,"median":-38.04671,"eighty":-33.303022,"marketCap":12470515860},{"date":"2026-02-13","current":-37.506904,"twenty":-42.335079,"median":-38.011119,"eighty":-33.387129,"marketCap":12202011930},{"date":"2026-02-20","current":-39.795685,"twenty":-42.275235,"median":-38.202679,"eighty":-33.413439,"marketCap":12927967000},{"date":"2026-02-27","current":-37.9711,"twenty":-42.061223,"median":-38.358648,"eighty":-33.438876,"marketCap":12470515860},{"date":"2026-03-06","current":-32.876582,"twenty":-42.035836,"median":-37.973315,"eighty":-33.326804,"marketCap":10710323430},{"date":"2026-03-13","current":-37.800338,"twenty":-41.938243,"median":-37.9711,"eighty":-33.411645,"marketCap":12371069960},{"date":"2026-03-20","current":-39.652105,"twenty":-41.914066,"median":-38.162788,"eighty":-33.431073,"marketCap":12927967000},{"date":"2026-03-27","current":-45.563334,"twenty":-41.938243,"median":-38.422097,"eighty":-33.438876,"marketCap":14817439100},{"date":"2026-04-02","current":-73.055706,"twenty":-42.061577,"median":-38.676054,"eighty":-33.441386,"marketCap":17572695150},{"date":"2026-04-10","current":-74.98239,"twenty":-42.364587,"median":-38.815397,"eighty":-33.443763,"marketCap":18175244000},{"date":"2026-04-17","current":-69.940613,"twenty":-42.73421,"median":-39.081216,"eighty":-33.482556,"marketCap":16960268450},{"date":"2026-04-24","current":-67.940785,"twenty":-43.090538,"median":-39.261059,"eighty":-33.558052,"marketCap":16476253800},{"date":"2026-04-30","current":-65.13036,"twenty":-44.026925,"median":-39.582143,"eighty":-33.605745,"marketCap":15804560000},{"date":"2026-05-08","current":-55.847576,"twenty":-44.547984,"median":-39.760016,"eighty":-33.640661,"marketCap":16030679080},{"date":"2026-05-15","current":-43.849045,"twenty":-45.37348,"median":-39.795589,"eighty":-33.697999,"marketCap":12619684710},{"date":"2026-05-22","current":-44.434352,"twenty":-44.931837,"median":-39.87359,"eighty":-33.778461,"marketCap":12758908970},{"date":"2026-05-29","current":-42.313126,"twenty":-44.693978,"median":-39.965338,"eighty":-33.850015,"marketCap":12192067340},{"date":"2026-06-05","current":-38.943344,"twenty":-44.633844,"median":-39.952945,"eighty":-33.989804,"marketCap":11237386700},{"date":"2026-06-12","current":-37.176407,"twenty":-44.416359,"median":-39.831455,"eighty":-34.116239,"marketCap":10720268020},{"date":"2026-06-18","current":-37.166904,"twenty":-44.344385,"median":-39.795685,"eighty":-34.459057,"marketCap":10740157200},{"date":"2026-06-26","current":-34.282345,"twenty":-44.322103,"median":-39.774315,"eighty":-34.282345,"marketCap":9861055444},{"date":"2026-07-03","current":-36.446991,"twenty":-44.194662,"median":-39.640092,"eighty":-34.070689,"marketCap":10491542450},{"date":"2026-07-10","current":-34.534018,"twenty":-44.124681,"median":-39.536207,"eighty":-34.070689,"marketCap":9928678656},{"date":"2026-07-17","current":-44.462046,"twenty":-44.326559,"median":-39.640092,"eighty":-34.242022,"marketCap":12828521100},{"date":"2026-07-24","current":-43.03924,"twenty":-44.356568,"median":-39.788614,"eighty":-34.393423,"marketCap":12420792910},{"date":"2026-07-31","current":-36.732388,"twenty":-44.331016,"median":-39.652105,"eighty":-34.443911,"marketCap":10620822120},{"date":"2026-08-07","current":-44.144483,"twenty":-44.255348,"median":-39.774315,"eighty":-34.478204,"marketCap":12788742740},{"date":"2026-08-14","current":-50.259709,"twenty":-44.44543,"median":-39.795685,"eighty":-34.516798,"marketCap":14578768940},{"date":"2026-08-21","current":-48.712147,"twenty":-45.096211,"median":-39.845109,"eighty":-34.555887,"marketCap":14161096160},{"date":"2026-08-28","current":-49.214108,"twenty":-45.572671,"median":-39.940552,"eighty":-34.653517,"marketCap":14310265010}],"updateTime":1788184405209},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09887\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2655827075","title":"Nanjing Leads Biolabs Completes Enrollment in Phase II Opamtistomig Trial for Advanced Biliary Tract Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2655827075","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655827075?lang=en_us&edition=fundamental","pubTime":"2026-07-30 17:46","pubTimestamp":1785404807,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs completes enrollment in Phase II Opamtistomig trial for advanced biliary tract cancerNanjing Leads Biolabs completed full enrollment of 70 patients in a Phase II study of LBL-024","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL2w0tzp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","HK0000500386.USD","BK1161","09887","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103606796","title":"LEADS BIOLABS-B (09887) Records a Major Securities Transfer Valued at HK$746 Million, Representing 7.10% of Total Shares, with 13.76 Million Shares Moved from China Securities Depository and Clearing Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=1103606796","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103606796?lang=en_us&edition=fundamental","pubTime":"2026-07-30 08:28","pubTimestamp":1785371298,"startTime":"0","endTime":"0","summary":"A significant change in the shareholding position of LEADS BIOLABS-B (09887) was recorded on July 29, according to the latest data from the Hong Kong Stock Exchange. The total market value of the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000252152.HKD","HK0000252160.HKD","HK0000500386.USD","09887","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161348079","title":"Hong Kong Stocks Update: LEADS BIOLABS-B (09887) Drops Over 7% Further, Kpc Pharmaceuticals Plans to Sell HKD 132 Million Stake, Founder Voluntarily Extends Lock-Up Period","url":"https://stock-news.laohu8.com/highlight/detail?id=1161348079","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161348079?lang=en_us&edition=fundamental","pubTime":"2026-07-28 14:18","pubTimestamp":1785219500,"startTime":"0","endTime":"0","summary":"LEADS BIOLABS-B (09887) shares tumbled more than 7% in early trading, adding to recent losses. As of the latest check, the stock was down 6.89% to HKD 54.05, with turnover reaching HKD 608 million....","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","BK0188","BK0028","600422","BK1161","BK4585","KCAI","BK0239","BK4588","VXUS","09887","HK0000252152.HKD","BK0060","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119611130","title":"Movement Alert｜LEADS BIOLABS-B Falls 5.51% in Regular Trading, Lock-Up Expiry Triggers Selling Pressure as Kunming Pharma Exits Position","url":"https://stock-news.laohu8.com/highlight/detail?id=1119611130","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119611130?lang=en_us&edition=fundamental","pubTime":"2026-07-28 09:43","pubTimestamp":1785202996,"startTime":"0","endTime":"0","summary":"On July 28, LEADS BIOLABS-B fell 5.51% in regular trading, trading at HK$56.7/share with turnover of HK$360 million, extending the prior session's decline.On the news front, the stock is facing...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"LEADS BIOLABS-B Falls as Lock-Up Expiry Triggers Selling Pressure as Kunming Pharma Exits Position","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654139620","title":"KPC Pharmaceuticals to Divest Stake in Nanjing Leads Biolabs","url":"https://stock-news.laohu8.com/highlight/detail?id=2654139620","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654139620?lang=en_us&edition=fundamental","pubTime":"2026-07-27 16:46","pubTimestamp":1785142001,"startTime":"0","endTime":"0","summary":"KPC Pharmaceuticals  will sell 2.4 million shares it holds in Nanjing Leads Biolabs  for a total of 132.2 million yuan, according to a Saturday disclosure to the Shanghai bourse.The divestment of the 1.2283% stake will help KPC focus on its core business and optimize its asset structure.The selling price will be determined according to the secondary market price of the time.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0188","HK0000500386.USD","09887","600422","BK0239","HK0000252160.HKD","HK0000252152.HKD","BK1161","BK0060","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146153512","title":"Hong Kong Stock Market Midday Review: Hang Seng Index Rises 0.81% as Xiaomi Leads the Blue Chips with a 7% Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=1146153512","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146153512?lang=en_us&edition=fundamental","pubTime":"2026-07-27 12:06","pubTimestamp":1785125180,"startTime":"0","endTime":"0","summary":"Hong Kong stocks saw a midday uptick, with the Hang Seng Index climbing 0.81%, or 203 points, to 25,166. The Hang Seng Tech Index advanced 1.69%. Morning session turnover reached HK$111.2...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002487","HXXD.SI","LU0345776255.USD","LU0611395673.USD","BK1149","HK0000500386.USD","LU0348783233.USD","LU0588545730.USD","LU0348825331.USD","SGXZ62798434.SGD","03423","LU0181495838.USD","LU0327786744.USD","BK1226","LU2778985437.USD","LU0211977185.USD","LU2226246903.HKD","LU0143863198.USD","BK1193","IE00B19Z5X02.USD","LU1251922891.USD","BK1502","LU0823413587.USD","LU0890818403.SGD","BK1610","LU1675838814.USD","LU0823426480.USD","LU1282648689.USD","02837","DRGN","LU0326950275.SGD","LU0634319403.HKD","LU1634259391.SGD","LU0441854154.USD","LU1969619763.USD","LU0359201885.HKD","LU1105468828.SGD","01797","SG9999004220.SGD","XIACY","LU0231483743.USD","LU0918141705.HKD","HK0000252160.HKD","LU0039217434.USD","LU2476274308.USD","LU0449509016.USD","HK0000252152.HKD","BK1189","07300","BK1516","BK1519","LU0348827113.USD","LU2097828474.EUR","81810","LU0235996351.USD","01141","LU0594300419.USD","09067","LU0149721374.USD","LU0164872284.USD","LU0140636845.USD","BK1161","LU1868837565.USD","LU2328871848.SGD","LU0588546209.SGD","LU2097828557.USD","LU0143863784.USD","LU1719994722.HKD","LU0054450605.USD","LU0348735423.USD","LU1282651048.USD","LU1770036033.HKD","LU0052750758.USD","BK1521","LU0823397103.USD","SG9999006597.SGD","LU0593848301.USD","LU0117841782.USD","LU0405327148.USD","LU0072462343.USD","002490","LU0469268626.HKD","LU0456827905.SGD","LU1048588211.SGD","LU0359202008.SGD","LU0823041008.USD","LU1868838027.USD","LU0499858438.USD","LU1188198961.HKD","LU0315178854.USD","BK1615","LU0561508036.HKD","LU2293587155.HKD","LU0823040885.USD","LU0862451753.SGD","LU0173614495.USD","BK1114","LU0348784397.USD","LU0499858602.USD","LU0417516571.SGD","LU0700851271.USD","LU0463099449.HKD","02252","BK1528","06681","LU0572944931.SGD","LU2039709279.SGD","LU0164865239.USD","LU0307460666.USD","01810","03067","09887","02160","LU0823413660.USD","LU1880383366.USD","LU1961090484.USD","LU0871576103.HKD","LU0293314216.USD","02282","LU0345775950.USD","LU0405327494.USD","LU2476274720.SGD","LU0640798160.USD","00200","00568","LU0244354667.USD","BK1147","LU0823039010.USD","LU0865486749.SGD","MCHmain","BK1100","LU0972618739.USD","03033","LU0169518387.USD","LU1323998911.USD","LU0797268264.HKD","BK1587","LU0605514214.HKD","LU0823038988.USD","LU0449515922.USD","LU0417516902.SGD","IE0032431581.USD","LU0254981946.USD","BK1205","BK1511","LU1813983027.USD","LU2257852520.SGD","SG9999003461.SGD","LU0594300179.USD","03115","HTImain","LU0348783662.USD","LU2087589342.USD","LU1956131251.USD","LU0588545490.SGD","LU1481107354.HKD","BK1228","02800","LU2399975544.HKD","LU0051755006.USD","LU2097828714.EUR","82800","83115","LU1224444064.USD","LU0918141887.USD","07500","LU1720050803.USD","00857","LU1880383440.USD","HSTECH","513600","BK1132","09115","LU0164880469.USD","LU2152927971.USD","LU2097828805.USD","00553","HSI","LU0314109678.HKD","LU0348816934.USD","LU1522347837.USD","LU1808992512.USD","LU0650527681.SGD","LU0540923850.HKD","LU1634259557.SGD","LU0531970944.HKD","LU0320764599.SGD","LU0348805143.USD","LU0214875030.USD","IE00BWDBJ730.SGD","BK1172","SGXZ86797644.SGD","BK1506","LU0417516738.SGD","LU0675040207.SGD","BK1589","IE00B3M56506.USD","IE0034224299.USD","MIUmain","LU0359201612.USD","BK1618","LU2097828631.EUR","LU1785774172.SGD","BK1617","BK1583","03037","03417","LU0823426308.USD","601857","03032","SG9999014674.SGD","LU1328277881.USD","BK1596","LU1981816686.USD","LU0287142896.SGD","LU0456846285.SGD","LU1115378108.SGD","IE00BQJZWZ67.USD","LU0348814723.USD","LU1497734951.SGD","SG9999002463.SGD","03088","BK1574","HK0000165453.HKD","BK1142","LU1794554557.SGD","08729","01081","07552","07226","LU1497733631.SGD","HSImain","03419","BK1202","BK1575","09088","BK1523","HK0000286598.CNH","LU0531971595.HKD","MCHVY","HHImain","LU1023057109.AUD","BK1607","LU1497733557.USD","LU1282651121.HKD","LU1831875114.USD","02209","LU0084288322.USD","LU0588545904.SGD","LU2294711473.HKD","LU0862451837.USD","LU0210526637.USD","02833","LU0823397285.USD","LU1303224171.USD","LU1770034418.SGD","LU0708995583.HKD","600775","SG9999001093.SGD","07200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653718166","title":"New Forecasts: Here's What Analysts Think The Future Holds For Nanjing Leads Biolabs Co., Ltd. (HKG:9887)","url":"https://stock-news.laohu8.com/highlight/detail?id=2653718166","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653718166?lang=en_us&edition=fundamental","pubTime":"2026-07-23 07:20","pubTimestamp":1784762457,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs Co., Ltd. ( HKG:9887 ) shareholders will have a reason to smile today, with the analysts making...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9887/nanjing-leads-biolabs-shares/news/new-forecasts-heres-what-analysts-think-the-future-holds-for-321","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9887/nanjing-leads-biolabs-shares/news/new-forecasts-heres-what-analysts-think-the-future-holds-for-321","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HK0000252160.HKD","HK0000252152.HKD","09887","BK1161","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175511625","title":"LEADS BIOLABS-B Shares Surge Over 11%, Marking a 30% Gain in Three Days on ESMO Research News","url":"https://stock-news.laohu8.com/highlight/detail?id=1175511625","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175511625?lang=en_us&edition=fundamental","pubTime":"2026-07-15 14:32","pubTimestamp":1784097144,"startTime":"0","endTime":"0","summary":"Shares of LEADS BIOLABS-B (09887) have surged by over 11% today, extending a rally that has seen the stock gain more than 30% over the past three trading sessions.As of the latest update, the stock...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","VXUS","HK0000252152.HKD","BK4585","BK4588","HK0000500386.USD","09887","KCAI","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156225075","title":"LEADS BIOLABS-B Shares Surge Over 15% as Key Drug Candidate LBL-024 Enters Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1156225075","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156225075?lang=en_us&edition=fundamental","pubTime":"2026-07-14 11:52","pubTimestamp":1784001137,"startTime":"0","endTime":"0","summary":"Shares of LEADS BIOLABS-B (09887) surged more than 15% during the morning trading session.As of the latest update, the stock is up 6.39%, trading at HK$63.30 with a turnover of HK$167 million.The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887","BK1161","HK0000500386.USD","HK0000252160.HKD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651192431","title":"Leads Biolabs Says Six Studies Accepted for Presentation at ESMO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2651192431","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651192431?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:58","pubTimestamp":1783933130,"startTime":"0","endTime":"0","summary":"Leads Biolabs says six studies accepted for presentation at ESMO 2026Nanjing Leads Biolabs flagged a potential catalyst as it secured Late-Breaking Abstract status for ESMO 2026, with the full submiss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL2gtKVv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887","BK1161","HK0000500386.USD","HK0000252160.HKD","HK0000252152.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140815382","title":"Leads Biolabs Highlights R&D Momentum with Six Abstracts Accepted by 2026 ESMO, Including Two Top-Tier Oral Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=1140815382","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140815382?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:43","pubTimestamp":1783932228,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs”, HK: 09887) reported that six of its latest oncology studies have been selected for presentation at the 2026 annual meeting of the European Society...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132253753","title":"LEADS BIOLABS-B Announces Multiple Research Presentations Selected for Prestigious 2026 ESMO Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=1132253753","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132253753?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:40","pubTimestamp":1783932034,"startTime":"0","endTime":"0","summary":"The biopharmaceutical company LEADS BIOLABS-B (ASX: 09887) has announced that six of its latest research findings have been accepted for presentation at the 2026 European Society for Medical Oncology...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887","BK1161","HK0000252152.HKD","HK0000252160.HKD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651194299","title":"Nanjing Leads Biolabs Says Six Clinical Studies Win Presentation Slots at 2026 ESMO Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2651194299","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651194299?lang=en_us&edition=fundamental","pubTime":"2026-07-13 16:37","pubTimestamp":1783931830,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs says six clinical studies win presentation slots at 2026 ESMO meetingNanjing Leads Biolabs outlined six studies accepted for presentation at the 2026 ESMO meeting in Madrid on Oc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL6cGTfx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000252160.HKD","HK0000252152.HKD","BK1161","HK0000500386.USD","09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143216016","title":"LEADS BIOLABS-B Surges Over 27% in Morning Session as Velixicon® Application Granted Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1143216016","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143216016?lang=en_us&edition=fundamental","pubTime":"2026-07-13 11:31","pubTimestamp":1783913508,"startTime":"0","endTime":"0","summary":"Shares of LEADS BIOLABS-B (09887) surged more than 27% in the morning trading session. At the time of writing, the stock was up 27.40%, trading at HK$63.60 with a turnover of HK$202 million. On July...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887","BK1161","IPOS","HK0000252152.HKD","HK0000252160.HKD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650619185","title":"Nanjing Leads Biolabs Co - Opamtistomig Bla for Advanced Ep-nec Granted Priority Review by China's Nmpa","url":"https://stock-news.laohu8.com/highlight/detail?id=2650619185","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650619185?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:55","pubTimestamp":1783673703,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43C013:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000252160.HKD","HK0000252152.HKD","HK0000500386.USD","BK1161","09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650318595","title":"Nanjing Leads Biolabs Co Ltd: Actively Advancing Relevant Pre-launch Commercialization Preparations","url":"https://stock-news.laohu8.com/highlight/detail?id=2650318595","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650318595?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:55","pubTimestamp":1783673703,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43C013:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000252152.HKD","BK1161","HK0000500386.USD","HK0000252160.HKD","09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185616","title":"Priority Review Granted to Pd-l1/4-1bb Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in Ep-nec","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185616","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650185616?lang=en_us&edition=fundamental","pubTime":"2026-07-10 16:55","pubTimestamp":1783673703,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nFWN43C013:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000500386.USD","09887","HK0000252152.HKD","BK1161","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650907770","title":"Nanjing Leads Biolabs' Cancer Drug Included in China Regulator's Priority Review List","url":"https://stock-news.laohu8.com/highlight/detail?id=2650907770","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650907770?lang=en_us&edition=fundamental","pubTime":"2026-07-10 15:08","pubTimestamp":1783667303,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs'  biologics license application for LBL-024 was approved for inclusion in priority review and approval procedure by China's National Medical Products Administration.The drug has been developed as monotherapy for the treatment of advanced extrapulmonary neuroendocrine carcinoma, according to a Friday Hong Kong bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["09887","BK1161","HK0000252160.HKD","HK0000252152.HKD","HK0000500386.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114500368","title":"LEADS BIOLABS-B's Novel Cancer Therapy LBL-024 Granted Priority Review in China for Advanced Neuroendocrine Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1114500368","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114500368?lang=en_us&edition=fundamental","pubTime":"2026-07-10 12:34","pubTimestamp":1783658060,"startTime":"0","endTime":"0","summary":"The biologics license application for LEADS BIOLABS-B's (ASX: 09887) investigational drug, VELIXIN™ (the PD-L1/4-1BB bispecific antibody oplitelimab, LBL-024), as a monotherapy for advanced...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","PD","LU1169589451.USD","BK1161","LU1169590202.USD","HK0000252160.HKD","HK0000252152.HKD","HK0000500386.USD","09887"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650901310","title":"Nanjing Leads Biolabs Says China Regulator Puts Lbl-024 Ep-nec Filing in Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2650901310","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650901310?lang=en_us&edition=fundamental","pubTime":"2026-07-10 12:28","pubTimestamp":1783657691,"startTime":"0","endTime":"0","summary":"Nanjing Leads Biolabs says China regulator puts LBL-024 EP-NEC filing in priority reviewNanjing Leads Biolabs’ China BLA for LBL-024 (opamtistomig) in advanced EP-NEC entered NMPA-CDE priority review.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260710:nNDL8LMSg9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000500386.USD","BK1161","HK0000252152.HKD","09887","HK0000252160.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":3,"totalSize":139,"code":"91000000","status":"200"}]}}